Advances and perspectives in the molecular diagnosis of head and neck cancer

Bibliography

• Jemal A, Siegel R, Ward E, Cancer statistics, 2006. CA Cancer J Clin 2006;56(2):106-30
   PubMed Web of Science ®Google Scholar
• Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2002;52(1):23-47
   PubMed Web of Science ®Google Scholar
• Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114(5):806-16
   PubMed Web of Science ®Google Scholar
• (NCI) NCI. Oral Cancer Screening (PDQ®); 2009.
   Google Scholar
• El-Naggar AK, Mao L, Staerkel G, Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 2001;3(4):164-70
   PubMed Web of Science ®Google Scholar
• Hoque MO, Begum S, Topaloglu O, Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 2004;64(15):5511-7
   PubMed Web of Science ®Google Scholar
• Hu S, Ewertz M, Tufano RP, Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab 2006;91(1):98-104
   PubMed Web of Science ®Google Scholar
• Lee A, Kim Y, Han K, Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of Breast. Arch Pathol Lab Med 2004;128(11):1251-6
   Web of Science ®Google Scholar
• Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol 2000;36(6):525-8
   PubMed Web of Science ®Google Scholar
• Palmisano WA, Divine KK, Saccomanno G, Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000;60(21):5954-8
   PubMed Web of Science ®Google Scholar
• Rosas SL, Koch W, da Costa Carvalho MG, Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61(3):939-42
   PubMed Web of Science ®Google Scholar
• Sanchez-Cespedes M, Esteller M, Wu L, Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000;60(4):892-5
   PubMed Web of Science ®Google Scholar
• Usadel H, Brabender J, Danenberg KD, Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62(2):371-5
   PubMed Web of Science ®Google Scholar
• Wadsworth JT, Somers KD, Cazares LH, Serum protein profiles to identify head and neck cancer. Clin Cancer Res 2004;10(5):1625-32
   PubMed Web of Science ®Google Scholar
• Wadsworth JT, Somers KD, Stack BC Jr, Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 2004;130(1):98-104
   PubMed Web of Science ®Google Scholar
• Wong IH, Zhang J, Lai PB, Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. Clin Cancer Res 2003;9(3):1047-52
   PubMed Web of Science ®Google Scholar
• Franceschi E, Tosoni A, Pozzati E, Brandes AA. Association between response to primary treatments and MGMT status in glioblastoma. Expert Rev Anticancer Ther 2008;8(11):1781-6
   PubMed Web of Science ®Google Scholar
• Carlson RW, Allred DC, Anderson BO, Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009;7(2):122-92
   PubMedGoogle Scholar
• Harichand-Herdt S, Zelnak A, O'Regan R. Endocrine therapy for the treatment of postmenopausal women with breast cancer. Expert Rev Anticancer Ther 2009;9(2):187-98
   PubMed Web of Science ®Google Scholar
• Osborne CK, Yochmowitz MG, Knight WA III, McGuire WL. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980;46(12 Suppl):2884-8
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Clark GM, Wong SG, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235(4785):177-82
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Godolphin W, Jones LA, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244(4905):707-12
   PubMed Web of Science ®Google Scholar
• Andl T, Kahn T, Pfuhl A, Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58(1):5-13
   PubMed Web of Science ®Google Scholar
• Gillison ML, Koch WM, Capone RB, Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92(9):709-20
   PubMed Web of Science ®Google Scholar
• Hafkamp HC, Speel EJ, Haesevoets A, A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003;107(3):394-400
   PubMed Web of Science ®Google Scholar
• Mork J, Lie AK, Glattre E, Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344(15):1125-31
   PubMed Web of Science ®Google Scholar
• Schwartz SM, Daling JR, Doody DR, Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90(21):1626-36
   PubMed Web of Science ®Google Scholar
• van Houten VM, Snijders PJ, van den Brekel MW, Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001;93(2):232-5
   PubMed Web of Science ®Google Scholar
• Wiest T, Schwarz E, Enders C, Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002;21(10):1510-7
   PubMed Web of Science ®Google Scholar
• Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989;115(5):621-5
   PubMed Web of Science ®Google Scholar
• Fouret P, Monceaux G, Temam S, Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997;123(5):513-6
   PubMed Web of Science ®Google Scholar
• Haraf DJ, Nodzenski E, Brachman D, Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996;2(4):755-62
   PubMed Web of Science ®Google Scholar
• Paz IB, Cook N, Odom-Maryon T, Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79(3):595-604
   PubMed Web of Science ®Google Scholar
• Ringstrom E, Peters E, Hasegawa M, Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002;8(10):3187-92
   PubMed Web of Science ®Google Scholar
• Ritchie JM, Smith EM, Summersgill KF, Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104(3):336-44
   PubMed Web of Science ®Google Scholar
• zur Hausen H. Papillomavirus infections–a major cause of human cancers. Biochim Biophys Acta 1996;1288(2):F55-78
   PubMed Web of Science ®Google Scholar
• Furniss CS, McClean MD, Smith JF, Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use. Ann Oncol 2009;20(3):534-41
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14(2):467-75
   PubMed Web of Science ®Google Scholar
• Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248(4951):76-9
   PubMed Web of Science ®Google Scholar
• Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006;24(17):2606-11
   PubMed Web of Science ®Google Scholar
• Lindel K, Beer KT, Laissue J, Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001;92(4):805-13
   PubMed Web of Science ®Google Scholar
• D'Souza G, Kreimer AR, Viscidi R, Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356(19):1944-56
   PubMed Web of Science ®Google Scholar
• Li W, Thompson CH, O'Brien CJ, Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003;106(4):553-8
   PubMed Web of Science ®Google Scholar
• Mellin H, Friesland S, Lewensohn R, Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000;89(3):300-4
   PubMed Web of Science ®Google Scholar
• Schwartz SR, Yueh B, McDougall JK, Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001;125(1):1-9
   PubMed Web of Science ®Google Scholar
• Weinberger PM, Yu Z, Haffty BG, Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24(5):736-47
   PubMed Web of Science ®Google Scholar
• Begum S, Gillison ML, Ansari-Lari MA, Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003;9(17):6469-75
   PubMed Web of Science ®Google Scholar
• Chuang AY, Chuang TC, Chang S, Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008;44(10):915-9
   PubMed Web of Science ®Google Scholar
• Smeets SJ, Hesselink AT, Speel EJ, A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121(11):2465-72
   PubMed Web of Science ®Google Scholar
• Zumbach K, Hoffmann M, Kahn T, Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer 2000;85(6):815-8
   PubMed Web of Science ®Google Scholar
• Gillison ML. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol 2006;24(36):5623-5
   PubMed Web of Science ®Google Scholar
• Capone RB, Pai SI, Koch WM, Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 2000;6(11):4171-5
   PubMed Web of Science ®Google Scholar
• Rocco JW, Leong CO, Kuperwasser N, p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006;9(1):45-56
   PubMed Web of Science ®Google Scholar
• Michaud WA, Nichols AC, Mroz EA, Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. Clin Cancer Res 2009;15(5):1645-54
   PubMed Web of Science ®Google Scholar
• Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005;5(5):341-54
   PubMed Web of Science ®Google Scholar
• Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 2006;24(17):2666-72
   PubMed Web of Science ®Google Scholar
• Rogers SJ, Harrington KJ, Rhys-Evans P, Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 2005;24(1):47-69
   PubMed Web of Science ®Google Scholar
• Ang KK, Berkey BA, Tu X, Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62(24):7350-6
   PubMed Web of Science ®Google Scholar
• Ishitoya J, Toriyama M, Oguchi N, Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 1989;59(4):559-62
   PubMed Web of Science ®Google Scholar
• Kearsley JH, Furlong KL, Cooke RA, Waters MJ. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer 1990;61(6):821-7
   PubMed Web of Science ®Google Scholar
• Maxwell SA, Sacks PG, Gutterman JU, Gallick GE. Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck. Cancer Res 1989;49(5):1130-7
   PubMed Web of Science ®Google Scholar
• Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53(15):3579-84
   PubMed Web of Science ®Google Scholar
• Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994;54(12):3153-9
   PubMed Web of Science ®Google Scholar
• Rubin Grandis J, Melhem MF, Gooding WE, Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90(11):824-32
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Atasoy BM, Daley FM, Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 2005;23(24):5560-7
   PubMed Web of Science ®Google Scholar
• Bonner JA, Harari PM, Giralt J, Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354(6):567-78
   PubMed Web of Science ®Google Scholar
• Karamouzis MV, Grandis JR, Argiris A. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. JAMA 2007;298(1):70-82
   PubMed Web of Science ®Google Scholar
• Califano J, van der Riet P, Westra W, Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56(11):2488-92
   PubMed Web of Science ®Google Scholar
• van der Riet P, Nawroz H, Hruban RH, Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 1994;54(5):1156-8
   PubMed Web of Science ®Google Scholar
• Nawroz H, Koch W, Anker P, Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2(9):1035-7
   PubMed Web of Science ®Google Scholar
• Mao L, Lee JS, Fan YH, Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996;2(6):682-5
   PubMed Web of Science ®Google Scholar
• Rosin MP, Cheng X, Poh C, Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6(2):357-62
   PubMed Web of Science ®Google Scholar
• Partridge M, Emilion G, Pateromichelakis S, Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol 1998;34(2):77-83
   PubMed Web of Science ®Google Scholar
• Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 2004;10(11):3607-13
   PubMed Web of Science ®Google Scholar
• Tabor MP, Brakenhoff RH, van Houten VM, Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001;7(6):1523-32
   PubMed Web of Science ®Google Scholar
• Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002;196(1):1-7
   PubMed Web of Science ®Google Scholar
• Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349(21):2042-54
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983;111(1):47-54
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983;301(5895):89-92
   PubMed Web of Science ®Google Scholar
• Bird AP. DNA methylation–how important in gene control? Nature 1984;307(5951):503-4
   PubMed Web of Science ®Google Scholar
• Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004;22(22):4632-42
   PubMed Web of Science ®Google Scholar
• Dunn BK. Hypomethylation: one side of a larger picture. Ann NY Acad Sci 2003;983:28-42
   PubMed Web of Science ®Google Scholar
• Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002;21(35):5400-13
   PubMed Web of Science ®Google Scholar
• Hanada M, Delia D, Aiello A, bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993;82(6):1820-8
   PubMed Web of Science ®Google Scholar
• Honda T, Tamura G, Waki T, Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer 2004;90(4):838-43
   PubMed Web of Science ®Google Scholar
• Nishigaki M, Aoyagi K, Danjoh I, Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res 2005;65(6):2115-24
   PubMed Web of Science ®Google Scholar
• Smith IM, Glazer CA, Mithani SK, Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer. PLoS ONE 2009;4(3):e4961
   PubMedGoogle Scholar
• Smith IM, Mydlarz WK, Mithani SK, Califano JA. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 2007;121(8):1724-8
   PubMed Web of Science ®Google Scholar
• Watt PM, Kumar R, Kees UR. Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia. Genes Chromosomes Cancer 2000;29(4):371-7
   PubMed Web of Science ®Google Scholar
• Frommer M, McDonald LE, Millar DS, A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992;89(5):1827-31
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myohanen S, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93(18):9821-6
   PubMed Web of Science ®Google Scholar
• Lo YM, Wong IH, Zhang J, Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res 1999;59(16):3899-903
   PubMed Web of Science ®Google Scholar
• Yamashita K, Upadhyay S, Osada M, Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002;2(6):485-95
   PubMed Web of Science ®Google Scholar
• Ai L, Vo QN, Zuo C, Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev 2004;13(1):150-6
   PubMed Web of Science ®Google Scholar
• Chang HW, Ling GS, Wei WI, Yuen AP. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer 2004;101(1):125-32
   PubMed Web of Science ®Google Scholar
• Dong SM, Sun DI, Benoit NE, Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 2003;9(10 Pt 1):3635-40
   PubMed Web of Science ®Google Scholar
• El-Naggar AK, Lai S, Clayman G, Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 1997;151(6):1767-74
   PubMed Web of Science ®Google Scholar
• Estecio MR, Youssef EM, Rahal P, LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene 2006;25(36):5018-26
   PubMed Web of Science ®Google Scholar
• Esteller M, Hamilton SR, Burger PC, Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59(4):793-7
   PubMed Web of Science ®Google Scholar
• Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006;7(1):77-82
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Nelson HH, Peters E, Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 2002;21(27):4231-6
   PubMed Web of Science ®Google Scholar
• Maruya S, Issa JP, Weber RS, Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 2004;10(11):3825-30
   PubMed Web of Science ®Google Scholar
• Merlo A, Herman JG, Mao L, 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1(7):686-92
   PubMed Web of Science ®Google Scholar
• Nayak CS, Carvalho AL, Jeronimo C, Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Laryngoscope 2007;117(8):1376-80
   PubMed Web of Science ®Google Scholar
• Ogi K, Toyota M, Ohe-Toyota M, Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 2002;8(10):3164-71
   PubMed Web of Science ®Google Scholar
• Reed AL, Califano J, Cairns P, High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56(16):3630-3
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Liloglou T, Rogers SN, Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 2006;94(4):561-8
   PubMed Web of Science ®Google Scholar
• Youssef EM, Lotan D, Issa JP, Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res 2004;10(5):1733-42
   PubMed Web of Science ®Google Scholar
• Marsit CJ, Christensen BC, Houseman EA, Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 2009;30(3):416-22
   PubMed Web of Science ®Google Scholar
• Chang HW, Chan A, Kwong DL, Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient. Int J Cancer 2003;105(6):851-5
   PubMed Web of Science ®Google Scholar
• Hamana K, Uzawa K, Ogawara K, Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma. Br J Cancer 2005;92(12):2181-4
   PubMed Web of Science ®Google Scholar
• Lopez M, Aguirre JM, Cuevas N, Gene promoter hypermethylation in oral rinses of leukoplakia patients--a diagnostic and/or prognostic tool? Eur J Cancer 2003 Nov;39(16):2306-9.
   PubMed Web of Science ®Google Scholar
• Nakahara Y, Shintani S, Mihara M, Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg 2006;35(4):362-5
   PubMed Web of Science ®Google Scholar
• Costello JF, Fruhwald MC, Smiraglia DJ, Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24(2):132-8
   PubMed Web of Science ®Google Scholar
• Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61(8):3225-9
   PubMed Web of Science ®Google Scholar
• Carvalho AL, Jeronimo C, Kim MM, Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008;14(1):97-107
   PubMed Web of Science ®Google Scholar
• He QY, Chen J, Kung HF, Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004;4(1):271-8
   PubMed Web of Science ®Google Scholar
• Koike H, Uzawa K, Nakashima D, Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 2005;27(1):59-67
   PubMed Web of Science ®Google Scholar
• Roesch-Ely M, Nees M, Karsai S, Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 2007;26(1):54-64
   PubMed Web of Science ®Google Scholar
• Sewell DA, Yuan CX, Robertson E. Proteomic signatures in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007;69(2):77-84
   PubMed Web of Science ®Google Scholar
• Gourin CG, Xia ZS, Han Y, Serum protein profile analysis in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132(4):390-7
   PubMed Web of Science ®Google Scholar
• Ye H, Wang A, Lee BS, Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics Proteomics 2008;5(2):85-94
   PubMedGoogle Scholar
• Fan AC, Deb-Basu D, Orban MW, Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nat Med 2009;15(5):566-71
   PubMed Web of Science ®Google Scholar
• Anker P, Mulcahy H, Chen XQ, Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999;18(1):65-73
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou X, St John MA, Wong DT. RNA profiling of cell-free saliva using microarray technology. J Dent Res 2004;83(3):199-203
   PubMed Web of Science ®Google Scholar
• Rieger-Christ KM, Mourtzinos A, Lee PJ, Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection. Cancer 2003;98(4):737-44
   PubMed Web of Science ®Google Scholar
• Wong LJ, Lueth M, Li XN, Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res 2003;63(14):3866-71
   PubMed Web of Science ®Google Scholar
• Li Y, St John MA, Zhou X, Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10(24):8442-50
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75(5):843-54
   PubMed Web of Science ®Google Scholar
• Scaria V, Hariharan M, Pillai B, Host-virus genome interactions: macro roles for microRNAs. Cell Microbiol 2007;9(12):2784-94
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6(11):857-66
   PubMed Web of Science ®Google Scholar
• Lujambio A, Ropero S, Ballestar E, Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007;67(4):1424-9
   PubMed Web of Science ®Google Scholar
• Saito Y, Liang G, Egger G, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006;9(6):435-43
   PubMed Web of Science ®Google Scholar
• Tran N, McLean T, Zhang X, MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007;358(1):12-7
   PubMed Web of Science ®Google Scholar
• Wong TS, Liu XB, Chung-Wai Ho A, Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 2008;123(2):251-7
   PubMed Web of Science ®Google Scholar
• Chang SS, Jiang WW, Smith I, MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008;123(12):2791-7
   PubMed Web of Science ®Google Scholar
• Liu X, Chen Z, Yu J, Zhou X. MicroRNA Profiling and Head and Neck Cancer. Comparative and Functional Genomics 2009. doi:10.1155/2009/837514
   Google Scholar
• Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009;15(8):2850-5
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Liechty KC, Gentry FD, Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66(6):3338-44
   PubMed Web of Science ®Google Scholar